Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Posaconazole intravenous solution formulations stabilized by substituted β-cyclodextrin

Posaconazole intravenous solution formulations stabilized by substituted β-cyclodextrin

US Patent 9358297 · Granted Jun 7, 2016

Estimated economic value: $137,219,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods 2025
Nasal and ophthalmic delivery of aqueous corticosteroid solutions2025
Modified release gamma-hydroxybutyrate formulations having improved pharmacokine2025
Methods of administering gamma hydroxybutyrate formulations after a high-fat mea2023
DPI formulation containing sulfoalkyl ether cyclodextrin2022
Composition containing sulfoalkyl ether cyclodextrin and latanoprost2022
Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods 2022
Injectable nitrogen mustard compositions comprising a cyclodextrin derivative an2021
Injectable melphalan compositions comprising a cyclodextrin derivative and metho2021
Injectable nitrogen mustard compositions comprising a cyclodextrin derivative an2020
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid2020
Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods 2020